ITERUM THERAPEUTICS PLC

ITRM NASDAQ
6.60
-0.10
-1.49%
Opening 10:13 08/21 EDT
Open
6.60
Prev Close
6.70
High
6.76
Low
6.60
Volume
3.18K
Avg Vol (3M)
8.51K
52 Week High
11.22
52 Week Low
4.700
% Turnover
0.02%
Market Cap
86.74M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ITERUM THERAPEUTICS PLC ITRM stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The Company is focused on developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens. The Company is developing sulopenem - the oral and intervenous (IV) penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative. It is a bioavailable, antibiotic covering gram-positive, gram-negative and anaerobic pathogen with in-vitro activity against multidrug-resistant pathogens, including Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia, coli and Klebsiella and pneumonia. It has demonstrated potent in vitro activity against all genera of Enterobacteriacease, in anaerobes such as Bacteroides, Prevotella, Porphyromonas, Fusobacterium and Peptostreptococcus, gram-positive organisms including methicillin-susceptible staphylococci, Streptococcus pyogenes and Streptococcus pneumonia.
MORE >

Recently

Name
Price
%Change